期刊
AMERICAN JOURNAL OF PSYCHIATRY
卷 161, 期 11, 页码 2115-2117出版社
AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.ajp.161.11.2115
关键词
-
类别
资金
- NCRR NIH HHS [M01 RR-00750] Funding Source: Medline
- NIMH NIH HHS [K23 MH-068627] Funding Source: Medline
Objective: The authors assessed the effects Of D-cycloserine on the core symptom of social impairment in subjects with autism. Method: Following a 2-week, single-blind placebo lead-in phase, drug-free subjects with autistic disorder were administered three different doses Of D-cycloserine during each of three 2-week periods. Measures used for subject ratings included the Clinical Global Impression (CGI) scale and Aberrant Behavior Checklist. Results: Significant improvement was found on the CGI and social withdrawal subscale of the Aberrant Behavior Checklist. D-Cycloserine was well tolerated at most of the doses used in this study. Conclusions: In this pilot study, D-Cycloserine treatment resulted in significant improvement in social withdrawal. Further controlled studies Of D-cycloserine in autism appear warranted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据